BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24438557)

  • 21. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
    Mu X; Lin S; Yang J; Chen C; Chen Y; Herzig MC; Washburn K; Halff GA; Walter CA; Sun B; Sun LZ
    PLoS One; 2013; 8(5):e63436. PubMed ID: 23704908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration.
    Romero D; Terzic A; Conley BA; Craft CS; Jovanovic B; Bergan RC; Vary CP
    Carcinogenesis; 2010 Mar; 31(3):359-66. PubMed ID: 19736306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
    Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
    Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TMEPAI promotes degradation of the NF-κB signaling pathway inhibitory protein IκBα and contributes to tumorigenesis.
    Li Y; Zhang Y; Li L; Zhang M; Song N; Zhao Q; Liu Z; Diao A
    Int J Biol Macromol; 2023 Apr; 235():123859. PubMed ID: 36868334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TMEPAI family: involvement in regulation of multiple signalling pathways.
    Itoh S; Itoh F
    J Biochem; 2018 Sep; 164(3):195-204. PubMed ID: 29945215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel.
    Wardhani BW; Puteri MU; Watanabe Y; Louisa M; Setiabudy R; Kato M
    J Exp Pharmacol; 2020; 12():17-26. PubMed ID: 32158279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma.
    Wang H; Pan JQ; Luo L; Ning XJ; Ye ZP; Yu Z; Li WS
    Mol Cancer; 2015 Feb; 14():2. PubMed ID: 25971746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
    Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
    Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PMEPA1/TMEPAI knockout impairs tumour growth and lung metastasis in MDA-MB-231 cells without changing monolayer culture cell growth.
    Abdelaziz M; Watanabe Y; Kato M
    J Biochem; 2019 May; 165(5):411-414. PubMed ID: 30873542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
    Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
    Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NRP1 regulates radiation-induced EMT via TGF-β/Smad signaling in lung adenocarcinoma cells.
    Chen Z; Gao H; Dong Z; Shen Y; Wang Z; Wei W; Yi J; Wang R; Wu N; Jin S
    Int J Radiat Biol; 2020 Oct; 96(10):1281-1295. PubMed ID: 32659143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DRAK2 participates in a negative feedback loop to control TGF-β/Smads signaling by binding to type I TGF-β receptor.
    Yang KM; Kim W; Bae E; Gim J; Weist BM; Jung Y; Hyun JS; Hernandez JB; Leem SH; Park T; Jeong J; Walsh CM; Kim SJ
    Cell Rep; 2012 Nov; 2(5):1286-99. PubMed ID: 23122956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGF-β-activated kinase 1 (Tak1) mediates agonist-induced Smad activation and linker region phosphorylation in embryonic craniofacial neural crest-derived cells.
    Yumoto K; Thomas PS; Lane J; Matsuzaki K; Inagaki M; Ninomiya-Tsuji J; Scott GJ; Ray MK; Ishii M; Maxson R; Mishina Y; Kaartinen V
    J Biol Chem; 2013 May; 288(19):13467-80. PubMed ID: 23546880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Novel Monoclonal Antibodies for Evaluation of Transmembrane Prostate Androgen-Induced Protein 1 (TMEPAI) Expression Patterns in Gastric Cancer.
    Karbyshev MS; Grigoryeva ES; Volkomorov VV; Kremmer E; Huber A; Mitrofanova IV; Kaigorodova EV; Zavyalova MV; Kzhyshkowska JG; Cherdyntseva NV; Choynzonov EL
    Pathol Oncol Res; 2018 Apr; 24(2):427-438. PubMed ID: 28584893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3-Phosphoinositide-dependent PDK1 negatively regulates transforming growth factor-beta-induced signaling in a kinase-dependent manner through physical interaction with Smad proteins.
    Seong HA; Jung H; Kim KT; Ha H
    J Biol Chem; 2007 Apr; 282(16):12272-89. PubMed ID: 17327236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smad phospho-isoforms direct context-dependent TGF-β signaling.
    Matsuzaki K
    Cytokine Growth Factor Rev; 2013 Aug; 24(4):385-99. PubMed ID: 23871609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGF-β/Smad signaling through DOCK4 facilitates lung adenocarcinoma metastasis.
    Yu JR; Tai Y; Jin Y; Hammell MC; Wilkinson JE; Roe JS; Vakoc CR; Van Aelst L
    Genes Dev; 2015 Feb; 29(3):250-61. PubMed ID: 25644601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer.
    Zhang Y; Zeng Y; Liu T; Du W; Zhu J; Liu Z; Huang JA
    Respir Res; 2019 Jul; 20(1):164. PubMed ID: 31331328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells.
    Noda D; Itoh S; Watanabe Y; Inamitsu M; Dennler S; Itoh F; Koike S; Danielpour D; ten Dijke P; Kato M
    Oncogene; 2006 Sep; 25(41):5591-600. PubMed ID: 16636667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
    Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.